SIGA Technologies Inc (NASDAQ:SIGA)

6.05
Delayed Data
As of Apr 26
 -0.06 / -0.98%
Today’s Change
2.85
Today|||52-Week Range
6.78
+24.74%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$472.7M

Company Description

SIGA Technologies, Inc. engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The company develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. The company was founded on December 28, 1995 and is headquartered in New York, NY.

Contact Information

SIGA Technologies, Inc.
27 East 62nd Street
New York New York 10065
P:(212) 672-9100
Investor Relations:

Employees

Shareholders

Other institutional7.01%
Individual stakeholders37.74%
Mutual fund holders0.00%

Top Executives

Phillip Louis GomezChief Executive Officer & Director
Daniel J. LuckshireSecretary, Chief Financial & Accounting Officer
Dennis E. HrubyChief Scientific Officer & Vice President
Robin E. AbramsChief Administrative Officer & General Counsel